<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00303030</url>
  </required_header>
  <id_info>
    <org_study_id>Biofeedback or injections</org_study_id>
    <nct_id>NCT00303030</nct_id>
  </id_info>
  <brief_title>A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence</brief_title>
  <official_title>A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian Foundation for Health and Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A short presentation of a randomized clinical trial of biofeedback and anal injections as a&#xD;
      first treatment option of faecal incontinence.&#xD;
&#xD;
      Background: Faecal incontinence affects mainly women who have suffered sphincter disruption&#xD;
      from vaginal delivery, but individuals of all ages can be affected. The treatment of this&#xD;
      debility is not uniform between institutions or internationally. Often is surgical&#xD;
      reconstruction of the anal sphincter performed, or other invasive, costly treatment options.&#xD;
&#xD;
      The study: We intend to conduct a randomized, controlled, clinical trial where we compare the&#xD;
      effect of two less invasive, less costly treatment options as a first alternative:&#xD;
      biofeedback and anal injections. Our hypothesis is that anal injections will give a better&#xD;
      and more lasting effect than biofeedback. The primary endpoint will be change in faecal&#xD;
      incontinence assessed by the St. Marks incontinence score. Secondary endpoints will include&#xD;
      change in quality of life and several physiological parameters. We intend to include 62&#xD;
      patients in both groups, 124 all together, from 2 centres in Norway. The observation time is&#xD;
      2 years. We plan to include the first patient April 2006, and conclude the study by December&#xD;
      2010. This study can contribute to a more appropriate treatment-algorithm for these patients.&#xD;
&#xD;
      Study group:&#xD;
&#xD;
        -  Barthold Vonen MD PhD, Department of gastroenterological surgery, University Hospital of&#xD;
           North Norway&#xD;
&#xD;
        -  Rolv-Ole Lindsetmo MD PhD, Department of gastroenterological surgery, University&#xD;
           Hospital of North Norway&#xD;
&#xD;
        -  Arvid Stordahl MD PhD., Department of Surgery, Østfold Hospital Fredrikstad&#xD;
&#xD;
        -  Ylva Sahlin MD PhD, Department of Surgery, Innlandet Hospital Hamar&#xD;
&#xD;
        -  Trond Dehli, MD, Department of gastroenterological surgery, University Hospital of North&#xD;
           Norway&#xD;
&#xD;
        -  Kjersti Mevik, Stud. Med, University of Tromso&#xD;
&#xD;
      Project manager: Trond Dehli&#xD;
&#xD;
      Funding, approvals, publication: This study is funded from Northern Norway Regional Health&#xD;
      Authority and The Institution of Norwegian Health- and rehabilitation-organizations. It has&#xD;
      been approved by the Regional Committee for Medical Research Ethics and Norwegian Social&#xD;
      Science Data Services. The results will be published in an international peer-reviewed&#xD;
      journal after the Vancouver-convention's guidelines. The results will also be presented at&#xD;
      national and international conferences.&#xD;
&#xD;
      Contact:&#xD;
&#xD;
      Trond Dehli, Department of gastroenterological surgery, University hospital North Norway,&#xD;
      Breivika, 9038 Tromsø trond.dehli@unn.no tlf: +47 776 26 000&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incontinence measured by St.Marks incontinence score</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related Quality of Life measures</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiologic measures</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Fecal Incontinence</condition>
  <arm_group>
    <arm_group_label>1. Anal injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2. Biofeedback</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>1. Anal injection</intervention_name>
    <description>Submucosal injection just above the linea dentata in the anal canal of 4 x 1 ml of dextranomere.</description>
    <arm_group_label>1. Anal injection</arm_group_label>
    <other_name>Solesta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>2. Biofeedback</intervention_name>
    <description>Training under the guidance of a physiotherapist with the help of a biofeedback device with an anal probe.</description>
    <arm_group_label>2. Biofeedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fecal incontinence lasting more than 6 months&#xD;
&#xD;
          -  St. Marks score of 4 or more&#xD;
&#xD;
          -  No known local or general neurological disease&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  No constipation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Total rupture of the sphincter of more than 120 degrees&#xD;
&#xD;
          -  Diabetes mellitus with late complications (neurological og cardiovascular)&#xD;
&#xD;
          -  Ulcus simplex/rectal ulcus&#xD;
&#xD;
          -  Anal/rectal prolapse&#xD;
&#xD;
          -  ileo-anal anastomosis&#xD;
&#xD;
          -  Cancer recti or cancer ani last 2 years&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barthold Vonen, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Tromsø, Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Innlandssykehuset Hamar</name>
      <address>
        <city>Hamar</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anorektallaboratoriet, Østfoldsykehuset Sarpsborg</name>
      <address>
        <city>Sarpsborg</city>
        <zip>1723</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avdeling for gastroenterologisk kirurgi, University hospital of North Norway</name>
      <address>
        <city>Tromso</city>
        <zip>9016</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <study_first_submitted>March 14, 2006</study_first_submitted>
  <study_first_submitted_qc>March 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2006</study_first_posted>
  <last_update_submitted>November 16, 2011</last_update_submitted>
  <last_update_submitted_qc>November 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fecal incontinence</keyword>
  <keyword>Biofeedback</keyword>
  <keyword>Patient Satisfaction</keyword>
  <keyword>Quality of LifeTreatment Outcome</keyword>
  <keyword>Injections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

